Raymond James & Associates’s Axalta AXTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$6.09M Buy
168,187
+54,746
+48% +$1.92M ﹤0.01% 1515
2024
Q2
$3.88M Buy
113,441
+15,160
+15% +$518K ﹤0.01% 1771
2024
Q1
$3.38M Sell
98,281
-136,261
-58% -$4.45M ﹤0.01% 1835
2023
Q4
$7.97M Buy
234,542
+3,390
+1% +$102K 0.01% 1249
2023
Q3
$6.22M Sell
231,152
-8,533
-4% -$250K 0.01% 1326
2023
Q2
$7.86M Sell
239,685
-36,077
-13% -$1.12M 0.01% 1207
2023
Q1
$8.35M Sell
275,762
-95,641
-26% -$2.75M 0.01% 1128
2022
Q4
$9.46M Sell
371,403
-67,125
-15% -$1.66M 0.01% 1026
2022
Q3
$9.23M Buy
438,528
+5,346
+1% +$131K 0.01% 1020
2022
Q2
$9.58M Sell
433,182
-3,295
-0.8% -$83.8K 0.01% 1004
2022
Q1
$10.7M Sell
436,477
-483,254
-53% -$13.5M 0.01% 1027
2021
Q4
$30.5M Buy
919,731
+3,335
+0.4% +$106K 0.02% 550
2021
Q3
$26.8M Buy
916,396
+680,566
+289% +$20.4M 0.02% 568
2021
Q2
$7.19M Buy
235,830
+136,488
+137% +$4.32M 0.01% 1257
2021
Q1
$2.94M Sell
99,342
-7,185
-7% -$206K ﹤0.01% 1771
2020
Q4
$3.04M Sell
106,527
-8,116
-7% -$221K ﹤0.01% 1628
2020
Q3
$2.54M Sell
114,643
-40,511
-26% -$939K ﹤0.01% 1607
2020
Q2
$3.5M Buy
155,154
+84,525
+120% +$1.73M ﹤0.01% 1408
2020
Q1
$1.22M Sell
70,629
-56,983
-45% -$1.46M ﹤0.01% 1855
2019
Q4
$3.88M Sell
127,612
-7,568
-6% -$223K ﹤0.01% 1411
2019
Q3
$4.08M Sell
135,180
-5,463
-4% -$161K 0.01% 1340
2019
Q2
$4.19M Sell
140,643
-51,133
-27% -$1.36M 0.01% 1326
2019
Q1
$4.83M Buy
191,776
+28,542
+17% +$735K 0.01% 1211
2018
Q4
$3.82M Buy
163,234
+10,859
+7% +$270K 0.01% 1233
2018
Q3
$4.44M Buy
152,375
+4,174
+3% +$125K 0.01% 1286
2018
Q2
$4.49M Buy
148,201
+4,066
+3% +$128K 0.01% 1255
2018
Q1
$4.35M Buy
144,135
+6,301
+5% +$197K 0.01% 1225
2017
Q4
$4.46M Sell
137,834
-3,840
-3% -$122K 0.01% 1185
2017
Q3
$4.1M Buy
141,674
+57,584
+68% +$1.74M 0.01% 1186
2017
Q2
$2.69M Buy
84,090
+1,618
+2% +$51.7K 0.01% 1387
2017
Q1
$2.66M Buy
82,472
+42,960
+109% +$1.28M 0.01% 1365
2016
Q4
$1.07M Buy
39,512
+15,496
+65% +$408K ﹤0.01% 1881
2016
Q3
$679K Buy
+24,016
New +$672K ﹤0.01% 2090
2016
Q1
Sell
-17,378
Closed -$463K 2931
2015
Q4
$463K Sell
17,378
-68,759
-80% -$1.92M ﹤0.01% 2025
2015
Q3
$2.18M Buy
86,137
+9,034
+12% +$268K 0.01% 1165
2015
Q2
$2.55M Buy
+77,103
New +$2.55M 0.01% 1185

Other funds holding AXTA

Raymond James & Associates's AXTA Position: Q3 2024 in Review

Raymond James & Associates increased its Axalta (AXTA) stake by 48% in Q3 2024, buying an estimated $1.92M and bringing the position to 168,187 shares worth $6.09M. The position accounts for ﹤0.01% of the portfolio, ranked #1515.

Raymond James & Associates first reported a position in AXTA in Q2 2015 and has held it in 36 quarters since. The position peaked at $30.5M in Q4 2021. 401 funds tracked by Wall St. Rank hold AXTA as of Q3 2024.

  • Raymond James & Associates held 168,187 shares of Axalta worth $6.09M as of Q3 2024.
  • Raymond James & Associates bought 54,746 Axalta shares in Q3 2024, an estimated $1.92M.
  • Axalta made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #1515 holding.
  • Raymond James & Associates first reported a position in Axalta in Q2 2015 and has held it in 36 quarters since.
  • Raymond James & Associates's Axalta position peaked at $30.5M in Q4 2021.
  • 401 funds tracked by Wall St. Rank held Axalta as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.